View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOJ/DEA | RIN: 1117-AB51 | Publication ID: Spring 2019 |
Title: ●Registration and Reregistration Fees for Controlled Substance and List I Chemical Registrants | |
Abstract:
DEA proposes adjusting the fee schedule for DEA registration and reregistration fees necessary to recover the costs of its Diversion Control Program relating to the registration and control of the manufacture, distribution, dispensing, importation and exportation of controlled substances and List I chemicals as mandated by the Controlled Substances Act. |
|
Agency: Department of Justice(DOJ) | Priority: Economically Significant |
RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: Yes | Unfunded Mandates: No |
EO 13771 Designation: Other | |
CFR Citation: 21 CFR 1301.13 21 CFR 1309.11 21 CFR 1309.21 | |
Legal Authority: 21 U.S.C. 821 21 U.S.C. 886a 21 U.S.C. 958(f) |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
Small Entities Affected: Businesses | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Lynnette M. Wingert Acting Section Chief Department of Justice Drug Enforcement Administration 8701 Morrissette Drive, Springfield, VA 22152 Phone:202 598-6812 Fax:202 353-1263 |